Advanced Surgical Therapies for Parkinson’s

color image of x-ray

Margot’s Story Twenty years ago, John Parkhurst and his wife, Margot Bartlett, moved to their cottage in Tiny, Ontario. That was six years after Margot, a former nurse, was first diagnosed with Parkinson’s disease.   “My doctor says I am the poster child for Parkinson,” she says, with all the treatments, drug trials and medications her … Read more

Misbehaving Proteins

image of woman

At the University of Toronto, Dr. Lorraine Kalia, a neurologist and neuroscientist, is investigating the role that a protein called alpha-synuclein plays in a familial type of Parkinson’s disease caused by a mutation in the LRRK2 gene. Although large clumps of alpha-synuclein have been incriminated in the death of dopamine-producing brain cells, Kalia is investigating smaller … Read more

Testing theories in a new experimental model

Before researchers can test drugs or other therapies intended to treat or cure Parkinson’s disease on people, they must first be sure the medication or treatment is both safe and effective. To do that, they need models of the disease. At McGill University, Dr. Philippe Huot, a neurologist and an assistant professor, is developing one such … Read more

Parliamentary Breakfast Calls for Investment in Collaboration

On April 24, 2018, Parkinson Canada hosted a breakfast reception on Parliament Hill. The breakfast was sponsored by Rob Oliphant, MP for Don Valley West, and friend of Parkinson Canada. The breakfast was well attended by MPs and Senators who are not only interested in Parkinson’s, but also those who have been touched by the … Read more